Receptos
Drug Discovery Company
Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.Founded in 2007
Homepage: http://www.receptos.com/
Total money raised: $35.8M
92121
10835 Road to the Cure
Suite #205
San Diego
USA CA
Suite #205
San Diego
USA CA
Phone: (858) 652-5700
Updated on Mar 27, 2013
Receptos at CrunchBase
Faheem Hasnain President and CEOReceptos at CrunchBase
Marcus F. Boehm Vice President, Chemistry and co-Founder
Chrysa Mineo Vice President, Corporate Development
James R. Schmidt Vice President, Finance and Administration
William Rastetter Chairman
Past
March, 2012
Receptos raised $10.8M in unattributed round
Receptos Raises $10.8M Toward New Round, Plans Phase II Trials 
fis.dowjones.com
November, 2009
Receptos raised $25M in a Series A round from ARCH Venture Partners, Flagship Ventures, Lilly Ventures, and Venrock
Receptos raises $25M in Series A 
fiercebiotech.com
2007
Receptos was founded in 2007